Drug News

Medindia's Press Release’ section provides the latest press release on Drug from across the world for the global audience. This page links to 12891 Drug press releases.

Neurologists On Sermo Eagerly Await Cladribine and Fingolimod But Initial Adoption Will Be Conservative

CAMBRIDGE, Mass., Jan. 6 Sermo (http:www.sermo.com), the world's largest online physician's community, today announced a new Sermo Event(TM) Report assessing physician perception of FDA's "refuse to file" (RTF) letter on EMD Serono's Cladribine ...


Watson Files FDA Application for Generic Nuvigil(R)

- Paragraph IV Litigation Underway - MORRISTOWN, N.J. , Jan. 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, ...

LifeVantage Granted Import Approval for Protandim(R) in Mexico

SAN DIEGO, Jan. 6 LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of science-based solutions to oxidative stress, announced today that the Company has received formal approval from the Mexican government to launch its ...

Amifampridine Phosphate Receives Marketing Approval in the EU for LEMS

NOVATO, Calif., Jan. 5 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the European Commission has granted marketing approval for 3,4-diaminopyridine (amifampridine phosphate), for the rare autoimmune disease Lambert Eaton ...

Despite FDA's Letter to Merck Serono, Oral Cladribine is Still Expected to be the First Oral Disease-Modifying Therapy to Launch for Multiple Sclerosis in the United States

Novartis/Mitsubishi Tanabe's FTY-720 Remains on Track for Launch in Early 2011, According to Findings from Decision Resources Decision Resources Decision Resources, Inc. Christopher Comfort Elizabeth ...

ADVENTRX Pharmaceuticals Submits ANX-530 New Drug Application

Company Contact: ADVENTRX Pharmaceuticals Brian Culley, Principal Executive Officer 858-552-0866 Investor Contact: Lippert/Heilshorn & Associates, Inc. Don Markley ([email protected]) ...

Prescription Drug Coupons Offer Best Savings on Prescription Drugs

WASHINGTON, Dec. 30 If you are looking for the best way to save money on your prescription drugs then FREEDRUGCARD.US is your best option. The free prescription assistance drug card program is sponsored by a non-profit organization and ...

FDA Issues Complete Response Letter for Ceftobiprole

CONTACTS : Media:  Ernie Knewitz, 908-927-2953 or Amy Firsching, 908-218-7583 Investor Relations:  Louise Mehrotra, 732-524-6491 ...

Amilpar - Distribution of Interest on Capital Stock

RIO DE JANEIRO, Dec. 29 Amilpar (Bovespa: AMIL3; Bloomberg: AMIL3 BZ and APAR ; Reuters: AMIL3.SA), the largest managed care organization in Brazil, informs its Shareholders that the Board of Directors of the Company, in a meeting held today, ...

Biostar Pharmaceuticals, Inc. to Launch Xin Aoxing Oleanolic Acid Capsules in Beijing and Shanghai

XIANYANG, China, Dec. 29 Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases ...

Drug News »

Tirzepatide Treats Obesity Even in Diabetics and Those With Other Complications

Tirzepatide Treats Obesity Even in Diabetics and Those With Other Complications

The presence of medical conditions associated with obesity does not affect the overall weight loss attained with the use of the anti-obesity drug tirzepatide. This finding is as per a study supported by the industry, and will be ...

GLP-1 Drugs for Diabetes and Obesity: May Reduce Risk of Acute Pancreatitis

GLP-1 Drugs for Diabetes and Obesity: May Reduce Risk of Acute Pancreatitis

A recent study showed that the medicines Glucagon-like peptide-1receptor agonists (known as GLP-1 receptor agonists) prescribed for type 2 diabetes and obesity...

Stomach Paralysis Risk Found in Users of Weight Loss Drugs

Stomach Paralysis Risk Found in Users of Weight Loss Drugs

In a concerning revelation, the utilization of popular diabetes and weight loss drugs has been associated with an elevated risk of stomach paralysis, a rare yet severe condition known as gastroparesis . Emerging from comprehensive ...

 Semaglutide's Multifaceted Benefits in Diabetes Treatment

Semaglutide's Multifaceted Benefits in Diabetes Treatment

Semaglutide , as highlighted by a groundbreaking study, offers substantial benefits by reducing the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality in patients diagnosed with type 2 diabetes and chronic kidney disease ( )....

From Pandemic to Poultry: COVID Shot Tech Targets H5N1 Bird Flu

From Pandemic to Poultry: COVID Shot Tech Targets H5N1 Bird Flu

In response to the worldwide surge in H5N1 cases, American researchers have created an experimental mRNA vaccine , leveraging COVID-19 vaccine technology, to combat avian flu infections ( ). Preclinical models, detailed in the journal Nature ...

More Drug News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.